Semnur Pharmaceuticals, Inc. - Common Stock (SMNR)

CUSIP: 81686G105

Q3 2026 13F Holders as of 30 Sep 2026

Share change
-102
SEC-reported price per share
$0.57
Number of holders
1
Value change
-$58
Number of sells
1

Security key

81686G105

Report period

Q3 2026

Institutions

1

Top holders

1

Ownership snapshot

Top reported holders of SMNR - Semnur Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Scilex Holding Co
Disclosed value leader
Scilex Holding Co
Comparable rows
1/6
Latest evidence
30 Jun 2026
3/4/5 13D/G 13F Lead comparable stake: 79% 5 rows are not safely comparable across share classes. 13D/G row: Scilex Holding Co

Quick read

Scilex Holding Co leads the comparable SEC ownership view at 79%.

1 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Scilex Holding Co's linked filing trail.
Comparable ownership Top 1
Scilex Holding Co 79%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 6 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Scilex Holding Co
3/4/5 13D/G
10%+ Owner · Scilex Holding Company
79%
Reported 13D/G · 15 Jun 2026
$2,916,940,084
181,520,112 shares
— 15 Jun 2026
Scilex, Inc.
3/4/5
10%+ Owner
—
denominator unverified
$1,815,201
181,520,112 shares
— 15 Jun 2026
Denali Capital Global Investments LLC
3/4/5
10%+ Owner
—
denominator unverified
—
1,432,500 shares
— 30 Aug 2024
Jiandong Xu
3/4/5
10%+ Owner
—
denominator unverified
—
1,432,500 shares
— 30 Aug 2024
GAMMA Investing LLC
13F
Company
13F
—
denominator unverified
$58
116 shares
— 30 Jun 2026
RHUMBLINE ADVISERS
13F
Company
13F
—
denominator unverified
$15
30 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1
Shares
14
Rows available
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
2
Q3 2026 holders
1
Holder diff
-1
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .